• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Pharma & Human Health

Editor's Choice

Mental Health and the Brain-Gut-Microbiota Axis: Fundamental Importance of Diet

April 3, 2025 Microbiome Times

The Mediterranean diet is regarded as the most beneficial diet from a mental health perspective. The benefits of such a diet are mediated significantly through the brain- gut-microbiota axis. Abnormalities in this axis have been described in the most […]

Pharma & Human Health

New study sheds light on how bacteria ‘vaccinate’ themselves with genetic material from dormant viruses

March 27, 2025 Microbiome Times

Like people, bacteria get invaded by viruses. In bacteria, the viral invaders are called bacteriophages, derived from the Greek word for bacteria-eaters, or in shortened form, “phages.” Scientists have sought to learn how the single-cell […]

Editor's Choice

Novel In vitro Model Replicates Intestinal Microbiota Composition Without Requiring Anaerobic Incubation

March 25, 2025 Microbiome Times

The majority of the gut microbiota is unculturable using standard laboratory techniques, which has been well-documented since the advent of next generation sequencing in microbiome research. This limitation makes it difficult to characterise the phenotype […]

Finance

PepsiCo to Acquire fast-growing prebiotic soda brand for $1.95 billion

March 21, 2025 Microbiome Times

PepsiCo, Inc. (NASDAQ: PEP) (“PepsiCo”) announced on Monday that it has entered into a definitive agreement to acquire poppi, a fast-growing prebiotic soda brand, for $1.95 billion, including $300 million of anticipated cash tax benefits for a […]

Pharma & Human Health

Bloom Science Demonstrates Durable Weight Loss in Overweight Individuals in Phase 1 Trial of BL-001 

March 7, 2025 Microbiome Times

Bloom Science, Inc., a clinical-stage biotech company focused on the development of novel therapies for metabolic and neurological disorders, today announced that BL-001, an investigational oral therapy designed to replicate the positive effects of the ketogenic […]

Editor's Choice

Dynamic Microbiome Abundance Profiling: A new tool to solve challenges in microbiome analysis

March 5, 2025 Microbiome Times

With bacterial strains of the same species exhibiting remarkably different characteristics, it is vital biotic developers accurately characterise what strains are present in their product. This enables developers to maximise the biotics’ therapeutic potential, provide […]

Pharma & Human Health

Synthetic microbiome therapy suppresses bacterial infection without antibiotics

March 5, 2025 Microbiome Times

A synthetic microbiome therapy, tested in mice, protects against severe symptoms of a gut infection that is notoriously difficult-to-treat and potentially life threatening in humans, according to a team of researchers at Penn State. The […]

Finance

BiomX Announces a Series of Financings for Aggregate Gross Proceeds of $12 Million

February 26, 2025 Microbiome Times

BiomX Inc. (NYSE American: PHGE, the “Company” or “BiomX”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that it has entered into a securities purchase agreement […]

Editor's Choice

Scientists decode diet from stool DNA – no questions asked

February 24, 2025 Microbiome Times

Scientists have developed a breakthrough method to track diet using stool metagenomic data. Developed by researchers at the Institute for Systems Biology (ISB), the new method, called MEDI (Metagenomic Estimation of Dietary Intake), detects food-derived […]

Editor's Choice

Hervé Affagard talks Phase 3 results, the regulatory landscape and industry collaborations

February 20, 2025 Microbiome Times

In early January MaaT Pharma made waves in the pharma world with the announcement of positive topline results for their phase 3 trial of MaaT013 in acute Graft-versus-Host Disease. With robust efficacy and safety data, […]

Pharma & Human Health

Global “sisterhood” seeks to understand what makes a healthy vaginal microbiome

February 12, 2025 Microbiome Times

Vaginas host a complex microcosm of bacteria and yeasts that can fluctuate over time. However, little is known about these microbial communities and their roles in a person’s health, and 9 out of 10 studies […]

Posts navigation

« 1 2 3 … 82 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • DynaMAP – Precision Metagenomics beyond Sequencing
    May 27, 2025
  • The Selection of a Pre-Clinical Model is Driven by the Specific Research Question
    May 13, 2025
  • Mental Health and the Brain-Gut-Microbiota Axis: Fundamental Importance of Diet
    April 3, 2025
  • Novel In vitro Model Replicates Intestinal Microbiota Composition Without Requiring Anaerobic Incubation
    March 25, 2025
  • Dynamic Microbiome Abundance Profiling: A new tool to solve challenges in microbiome analysis
    March 5, 2025
sign up

Sign up to the Microbiome Times newsletter